Pharmacological targeting of Fc receptor and FcRn pathways: Therapeutic antibody engineering in immune-mediated disorders
- DOI
- 10.1016/j.ejphar.2026.179461
- Published
- 2026-12
- Container
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179461,
title = {Pharmacological targeting of Fc receptor and FcRn pathways: Therapeutic antibody engineering in immune-mediated disorders},
author = {Saeed Mobini and Milad Chizari and Elham Rismani and Mohammadjavad Sadrzadeh and Arezoo Khosravi and Ali Zarrabi and Massoud Vosough},
year = {2026},
journal = {European Journal of Pharmacology},
doi = {10.1016/j.ejphar.2026.179461},
url = {https://doi.org/10.1016/j.ejphar.2026.179461}
}RIS
TY - JOUR TI - Pharmacological targeting of Fc receptor and FcRn pathways: Therapeutic antibody engineering in immune-mediated disorders AU - Saeed Mobini AU - Milad Chizari AU - Elham Rismani AU - Mohammadjavad Sadrzadeh AU - Arezoo Khosravi AU - Ali Zarrabi AU - Massoud Vosough PY - 2026 JO - European Journal of Pharmacology DO - 10.1016/j.ejphar.2026.179461 UR - https://doi.org/10.1016/j.ejphar.2026.179461 ER -
APA
Mobini, S., Chizari, M., Rismani, E., Sadrzadeh, M., Khosravi, A., Zarrabi, A., & Vosough, M. (2026). Pharmacological targeting of Fc receptor and FcRn pathways: Therapeutic antibody engineering in immune-mediated disorders. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.179461
Source records
- crossref · retrieved 2026-11-05T01:35:08.099Z